BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Castle Biosciences 



Houston  Texas    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS




Industry
Diagnostics






 Company News
Castle Biosciences’ Multi-Analyte Test Successfully Identifies Esophageal Cancer Patients Who Are Extremely Resistant To Standard Treatment Of Chemoradiation Therapy 10/23/2014 10:34:28 AM
Castle Biosciences Snags $11.8 Million Financing 8/13/2014 6:37:59 AM
Study Shows Castle Biosciences’ Gene Expression Profile Test Successfully Identified High Risk Disease In A Cohort Of 217 Melanoma Patients Who Underwent Sentinel Lymph Node Biopsy 6/2/2014 12:49:56 PM
Castle Biosciences' Esophageal Cancer Test Accurately Predicts Pre-Surgical Treatment Response 6/2/2014 9:13:13 AM
Castle Biosciences' Melanoma Gene Expression Profile Test To Be Subject Of Presentation At American Society of Clinical Oncology Annual Meeting 5/15/2014 6:43:25 AM
Castle Biosciences' Esophageal Cancer Test Identifies Patients Who Are Resistant To Standard Pre-Surgical Chemoradiation Therapy 5/6/2014 9:42:02 AM
Castle Biosciences' Mesothelioma Molecular Test Accurately Stratifies Survival Risk Under Surgical And Non-Surgical Treatment Plans 4/29/2014 10:54:36 AM
Castle Biosciences Announces Data Demonstrating Ability To Identify Esophageal Cancer Patients Resistant To Standard Pre-Surgical Treatment Of Chemotherapy And Radiation 1/16/2014 10:20:58 AM
Castle Biosciences Launches Tissue Repository for Eye Cancer Patients 9/30/2013 9:39:21 AM
Castle Biosciences Genetic Test Highly Accurate in Differentiating Thymomas From Thymic Carcinoma Tumors 9/25/2013 10:31:20 AM
12